About John Ripple
Form D filings for Lucy Therapeutics from 2020 to 2024 list John Ripple as director.
John Ripple first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name John Ripple in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Ripple works with at each company, as listed on that company's latest Form D.
Lucy Therapeutics, Inc. · Form D/A, May 2, 2024